Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Prognostic significance of minimal residual disease detection and PML/RAR-α isoform type: Long-term follow-up in acute promyelocytic leukemia (APL)
    Meeting Abstract

    Jurcic, J. G.; Miller, W. H. Jr; DeBlasio, A.; Scheinberg, D. A.; Warrell, R. P. Jr
    Blood (1996)

    Fulltext@MSK | Save
  • Construction of a single chain antibody targeting the human myeloid cell antigen CD33
    Meeting Abstract

    Chang, E.; Soong, N.; Scheinberg, D. A.; Anderson, F. A.; Douer, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Consolidation therapy with high-dose cyclophosphamide (HDC) reduces minimal residual disease in patients with chronic lymphocytic leukemia (CLL) treated with fludarabine as induction therapy
    Meeting Abstract

    Weiss, M.; Glenn, M.; Maslak, P.; Rahman, Z.; Megherian, L.; Noy, A.; Zelenetz, A.; Scheinberg, D.; Golde, D.
    Blood (1996)

    Fulltext@MSK | Save
  • Economic evaluation of G-CSF use in the therapy of adult acute myelogenous leukemia (AML)
    Meeting Abstract

    Maslak, P.; Weiss, M.; Berman, E.; Tyson, D.; Scheinberg, D.
    Blood (1996)

    Fulltext@MSK | Save
  • High-dose infusional humanized anti-CD33 M195: Prospects for treating minimal disease in myeloid leukemia
    Meeting Abstract

    Caron, P. C.; Jurcic, J. G.; Dumont, L.; Tyson, D.; Scheinberg, D. A.
    Blood (1996)

    Fulltext@MSK | Save
  • Initial clinical study of a novel organic arsenical, melarsoprol, in patients with advanced leukemia
    Meeting Abstract

    Soignet, S.; Tong, W. P.; Gabrilove, J.; Scheinberg, D. A.; Pandolfi, P. P.; Warrell, R. P. Jr
    Blood (1996)

    Fulltext@MSK | Save
  • Clonotypic PCR confirms minimal residual disease (MRD) in CLL nodular PR: Preliminary results from a sequential treatment CLL protocol
    Meeting Abstract

    Noy, A.; Verma, R.; Rahman, Z. U.; Glenn, M.; Maslak, P.; Weiss, M.; Zelenetz, A. D.
    Blood (1996)

    Fulltext@MSK | Save
  • Effect of G-CSF and GM-CSF on multidrug resistant (MDR) leukemia cells
    Meeting Abstract

    Berman, E.; McBride, M.
    Blood (1996)

    Fulltext@MSK | Save
  • Organic arsenical melarsoprol shows growth suppressive activity via programmed cell death on APL and other myeloid and lymphoid leukemia derived cell lines
    Meeting Abstract

    Rivi, R.; Calleja, E.; König, A.; Lai, L.; Gambacorti-Passerini, C.; Scheinberg, D.; Gabrilove, J. L.; Warrell, R. P. Jr; Pandolfi, P. P.
    Blood (1996)

    Fulltext@MSK | Save
  • Noninvasive evaluation of the bone marrow
    Journal Article

    Jakubowski, A.; Scheinberg, D. A.
    Journal of Nuclear Medicine (1996)

    Fulltext@MSK | Save